Cargando…
Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software
The global disruption caused by the 2020 coronavirus pandemic stressed the supply chain of many products, including pharmaceuticals. Multiple drug repurposing studies for COVID-19 are now underway. If a winning therapeutic emerges, it is unlikely that the existing inventory of the medicine, or even...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677791/ https://www.ncbi.nlm.nih.gov/pubmed/34916512 http://dx.doi.org/10.1038/s41467-021-27547-3 |